Drug Type Prophylactic vaccine |
Synonyms- |
Action inhibitors |
Mechanism SARS-CoV-2 N protein inhibitors(SARS-CoV-2 N protein inhibitors), SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Severe Acute Respiratory Syndrome | Phase 3 | Canada | 29 Nov 2021 | |
COVID-19 | Phase 1 | Canada | 03 Jan 2022 | |
COVID-19 | Phase 1 | Canada | 03 Jan 2022 |